相关实验视频
Updated: May 7, 2025

11:58
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
37.6K
多巴胺增强了对帕金森病的亲社会努力的动机
Jamie Talbot1,2, Jo Cutler1,2, Marin Tamm3
1Centre for Human Brain Health, School of Psychology University of Birmingham, B15 2TT, UK.
概括
多巴胺药物增加了帕金森病患者的亲社会努力. 这表明多巴胺在激励个人为他人的利益而付出努力方面发挥着关键作用.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 行为经济学是一种行为经济学.
背景情况:
- 动机对于以目标为导向的行为至关重要,通常涉及为了获得奖励而付出努力.
- 多巴胺增强了自我奖励的努力,但其在亲社会努力中的作用仍然不清楚.
- 帕金森病 (PD) 涉及多巴胺退化,影响社会认知功能.
研究的目的:
- 调查多巴胺是否调节了为社会利益而付出努力的意愿.
- 为了比较帕金森病患者在服用药物和不服用药物的自我与其他人的努力.
主要方法:
- 37名男性和女性帕金森病患者完成了一项努力选择任务.
- 参与者可以选择努力获得更大的奖励或休息获得更小的奖励.
- 选择是为了自身利益或为了利益一个匿名的其他人,而在开启或关闭多巴胺类药物时.
主要成果:
- 帕金森病患者显示,他们更愿意为自己而努力,而不是为他人而努力.
- 当患者接受多巴胺激素药物时,这种自我-其他努力差异减少了.
- 多巴胺增强增加了为他人而付出努力的意愿.
结论:
- 多巴胺在激发亲社会努力方面发挥着重要作用.
- 在帕金森病中多巴胺增加增加了帮助他人的动力.
- 这项研究为亲社会行为的神经化学基础提供了新的见解.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
303
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
303
Neural Regulation
38.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
38.9K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
184
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
184
Egoism and Altruism
91.3K
Voluntary behavior with the intent to help other people is called prosocial behavior. Why do people help other people? Is personal benefit such as feeling good about oneself the only reason people help one another?
91.3K

